Related Experiment Video

Updated: May 24, 2026

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
10:48

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression

Published on: May 15, 2014

Orthopoxvirus targets for the development of new antiviral agents

Mark N Prichard1, Earl R Kern

  • 1Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, AL 35233-1711, United States. mprichard@peds.uab.edu

Antiviral Research
|March 13, 2012
PubMed

Insights

New research investments are yielding novel drugs and molecular targets for orthopoxvirus infections. This progress in antiviral drug development offers hope for treating poxvirus diseases and informs strategies for other viral infections.

Area of Science:

  • Virology
  • Drug Discovery
  • Infectious Diseases

Background:

  • Orthopoxvirus infections pose a significant public health concern.
  • Previous treatments for orthopoxvirus infections were limited.
  • Recent investments have spurred advancements in antiviral research.

Purpose of the Study:

  • To review progress in developing new anti-orthopoxvirus drugs.
  • To identify novel molecular targets for therapeutic intervention.
  • To discuss the vaccinia virus replication cycle for drug target identification.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of ongoing clinical trials for anti-poxvirus therapies.
  • Examination of viral replication cycles to pinpoint drug targets.

Main Results:

  • Identification of multiple new inhibitors targeting various stages of orthopoxvirus replication.
  • Advancement of several novel therapies into clinical trials.
  • Characterization of specific vaccinia virus gene products as potential drug targets.

Conclusions:

  • Current research efforts are likely to produce new treatments for orthopoxvirus infections.
  • The study of orthopoxvirus biology offers valuable insights for broader antiviral drug development.
  • Continued investment in this field is crucial for combating viral diseases.

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection09:25

Rapid, Seamless Generation of Recombinant Poxviruses using Host Range and Visual Selection

Published on: May 24, 2020

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...